BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 1712712)

  • 1. Clinical pharmacology of loop diuretics.
    Brater DC
    Drugs; 1991; 41 Suppl 3():14-22. PubMed ID: 1712712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics and pharmacodynamics of torasemide.
    Knauf H; Mutschler E
    Clin Pharmacokinet; 1998 Jan; 34(1):1-24. PubMed ID: 9474471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of diuretics in acute and chronic renal failure. Focus on torasemide.
    Risler T; Krämer B; Müller GA
    Drugs; 1991; 41 Suppl 3():69-79. PubMed ID: 1712716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-related effects of furosemide, bumetanide, and piretanide on the thick ascending limb function in the rat.
    Gutsche HU; Müller-Ott K; Brunkhorst R; Niedermayer W
    Can J Physiol Pharmacol; 1983 Feb; 61(2):159-65. PubMed ID: 6301665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How do loop diuretics act?
    Wittner M; Di Stefano A; Wangemann P; Greger R
    Drugs; 1991; 41 Suppl 3():1-13. PubMed ID: 1712711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of loop diuretics on fluid reabsorption from the rat proximal convoluted tubule.
    Greenwood SL; White SJ; Green R
    Exp Physiol; 1990 May; 75(3):375-82. PubMed ID: 2350515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the pharmacokinetics and pharmacodynamics of torasemide and furosemide in healthy volunteers.
    Lesne M
    Arzneimittelforschung; 1988 Jan; 38(1A):160-3. PubMed ID: 3370062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites.
    Gentilini P; La Villa G; Marra F; Carloni V; Melani L; Foschi M; Cotrozzi G; Quartini M; Chibbaro G; Tommasi AC; Bernareggi A; Simoni A; Buzzelli G; Laffi G
    J Hepatol; 1996 Oct; 25(4):481-90. PubMed ID: 8912147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of "high ceiling" diuretics on active salt transport in the cortical thick ascending limb of Henle's loop of rabbit kidney. Correlation of chemical structure and inhibitory potency.
    Schlatter E; Greger R; Weidtke C
    Pflugers Arch; 1983 Mar; 396(3):210-7. PubMed ID: 6844125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Torasemide. A review of its pharmacological properties and therapeutic potential.
    Friedel HA; Buckley MM
    Drugs; 1991 Jan; 41(1):81-103. PubMed ID: 1706990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The loop diuretic torasemide but not azosemide potentiates the anti-seizure and disease-modifying effects of midazolam in a rat model of birth asphyxia.
    Welzel B; Schmidt R; Kirchhoff L; Gramer M; Löscher W
    Epilepsy Behav; 2023 Feb; 139():109057. PubMed ID: 36586153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal actions of piretanide and three other "loop" diuretics.
    McNabb WR; Noormohamed FH; Brooks BA; Lant AF
    Clin Pharmacol Ther; 1984 Mar; 35(3):328-37. PubMed ID: 6697640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loop diuretics.
    Greger R; Wangemann P
    Ren Physiol; 1987; 10(3-4):174-83. PubMed ID: 3330836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacokinetics and pharmacodynamics of loop diuretics in renal failure.
    Risler T; Schwab A; Kramer B; Braun N; Erley C
    Cardiology; 1994; 84 Suppl 2():155-61. PubMed ID: 7954539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of piretanide, bumetanide and frusemide on electrolyte and urate excretion in normal subjects.
    Roberts CJ; Homeida M; Roberts F; Bogie W
    Br J Clin Pharmacol; 1978 Aug; 6(2):129-33. PubMed ID: 678389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rat NKCC2/NKCC1 cotransporter selectivity for loop diuretic drugs.
    Hannaert P; Alvarez-Guerra M; Pirot D; Nazaret C; Garay RP
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):193-9. PubMed ID: 11882915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Torasemide for the treatment of heart failure.
    Ishido H; Senzaki H
    Cardiovasc Hematol Disord Drug Targets; 2008 Jun; 8(2):127-32. PubMed ID: 18537599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive effect of bumetanide on contractile activity of ventricular cardiomyocytes.
    Kelso E; McDermott B; Silke B; Spiers P
    Eur J Pharmacol; 2000 Jul; 400(1):43-50. PubMed ID: 10913583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacology of loop diuretics: a comparative study.
    Ansuini R; Pulido M; Pupita G; Gaggi S; Pupita F
    Int J Clin Pharmacol Res; 1985; 5(2):113-21. PubMed ID: 4018941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits and risks of torasemide in congestive heart failure and essential hypertension.
    Brater DC
    Drug Saf; 1996 Feb; 14(2):104-20. PubMed ID: 8852525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.